Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

56.40
BATS BZX Real-Time Price
As of 9:38am ET
 +0.75 / +1.35%
Today’s Change
33.30
Today|||52-Week Range
59.05
+41.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues122.0M144.4M215.0M302.2M
 
 
 
 
 
Cost of Goods Sold4.8M7.5M9.6M7.1M
 
 
 
 
 
Depreciation And Amortization928.0K921.0K2.4M8.1M
 
 
 
 
 
 
Operating ExpensesGross Income116.3M136.0M203.0M287.0M
 
 
 
 
 
General Expenses92.1M118.3M148.8M187.5M
 
 
 
 
 
Research And Development19.6M29.1M42.8M49.6M
 
 
 
 
 
Total Operating Expenses97.8M126.8M160.8M202.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income24.2M17.7M54.2M99.5M
 
 
 
 
 
Extraordinary Credit2.8M193.0K448.0K76.0K
 
 
 
 
 
Extraordinary Charge-2.6M-2.3M-671.0K-295.0K
 
 
 
 
 
Interest Expense On Debt5.0M1.2M5.1M1.6M
 
 
 
 
 
Other Expenses39.0K38.0K-15.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income19.9M15.0M50.4M100.6M
 
 
 
 
 
Income Taxes0.00-956.0K-40.9M-43.3M
 
 
 
 
Net Income19.9M14.0M91.2M57.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.3M47.5M49.5M50.8M
 
 
 
 
 
Shares To Calculate EPS Diluted50.6M51.2M51.7M53.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.32$0.28$1.76$1.08
 
 
 
 
 
EPS Diluted$0.32$0.28$1.76$1.08